(NASDAQ: LIN) Linde's forecast annual revenue growth rate of 6.19% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.99%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.09%.
Linde's revenue in 2026 is $33,504,000,000.On average, 28 Wall Street analysts forecast LIN's revenue for 2026 to be $16,774,206,412,390, with the lowest LIN revenue forecast at $15,722,170,473,100, and the highest LIN revenue forecast at $18,069,989,693,140. On average, 22 Wall Street analysts forecast LIN's revenue for 2027 to be $17,682,422,081,240, with the lowest LIN revenue forecast at $16,202,660,922,070, and the highest LIN revenue forecast at $19,090,273,105,190.
In 2028, LIN is forecast to generate $18,868,939,312,370 in revenue, with the lowest revenue forecast at $17,887,412,661,510 and the highest revenue forecast at $20,202,078,507,520.